Global POCT Molecular Diagnostics Market Growth 2026-2032
The global POCT Molecular Diagnostics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
POCT Molecular Diagnostics refers to the use of molecular testing techniques in Point-of-Care Testing (POCT) settings. Point-of-Care Testing involves performing medical diagnostic tests near the patient, often at the bedside or in a decentralized setting, rather than sending samples to a central laboratory for analysis. Molecular diagnostics, on the other hand, focuses on identifying and analyzing specific genetic material, such as DNA or RNA, to diagnose diseases, detect pathogens, and monitor treatment responses.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “POCT Molecular Diagnostics Industry Forecast” looks at past sales and reviews total world POCT Molecular Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected POCT Molecular Diagnostics sales for 2026 through 2032. With POCT Molecular Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POCT Molecular Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global POCT Molecular Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on POCT Molecular Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global POCT Molecular Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POCT Molecular Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POCT Molecular Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of POCT Molecular Diagnostics market by product type, application, key manufacturers and key regions and countries.
POCT Molecular Diagnostics refers to the use of molecular testing techniques in Point-of-Care Testing (POCT) settings. Point-of-Care Testing involves performing medical diagnostic tests near the patient, often at the bedside or in a decentralized setting, rather than sending samples to a central laboratory for analysis. Molecular diagnostics, on the other hand, focuses on identifying and analyzing specific genetic material, such as DNA or RNA, to diagnose diseases, detect pathogens, and monitor treatment responses.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “POCT Molecular Diagnostics Industry Forecast” looks at past sales and reviews total world POCT Molecular Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected POCT Molecular Diagnostics sales for 2026 through 2032. With POCT Molecular Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POCT Molecular Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global POCT Molecular Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on POCT Molecular Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global POCT Molecular Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POCT Molecular Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POCT Molecular Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of POCT Molecular Diagnostics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Molecular Point-of-Care Diagnostics
- Near-Patient Molecular
Segmentation by Application:
- Microbiology Laboratory
- Hospital
- Clinic
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ustar Biotechnologies (Hangzhou) Ltd.
- Cepheid
- Abbott Laboratories
- Roche Holding AG
- BioFire Diagnostics
- Beijing Bohui Innovat Biotech Grp Co Ltd.
- CapitalBio Corporation
- Daan Gene
- Sansure Biotech
- Coyote Bioscience Co., Ltd.
- Genmark Diagnostics, Inc.
- Mobidiag
- Wondfo
Key Questions Addressed in this Report
- What is the 10-year outlook for the global POCT Molecular Diagnostics market?
- What factors are driving POCT Molecular Diagnostics market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do POCT Molecular Diagnostics market opportunities vary by end market size?
- How does POCT Molecular Diagnostics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global POCT Molecular Diagnostics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for POCT Molecular Diagnostics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for POCT Molecular Diagnostics by Country/Region, 2021, 2025 & 2032
2.2 POCT Molecular Diagnostics Segment by Type
2.2.1 Molecular Point-of-Care Diagnostics
2.2.2 Near-Patient Molecular
2.2.3 POCT Molecular Diagnostics Sales by Type
2.2.3.1 Global POCT Molecular Diagnostics Sales Market Share by Type (2021-2026)
2.2.3.2 Global POCT Molecular Diagnostics Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global POCT Molecular Diagnostics Sale Price by Type (2021-2026)
2.3 POCT Molecular Diagnostics Segment by Application
2.3.1 Microbiology Laboratory
2.3.2 Hospital
2.3.3 Clinic
2.3.4 POCT Molecular Diagnostics Sales by Application
2.3.4.1 Global POCT Molecular Diagnostics Sale Market Share by Application (2021-2026)
2.3.4.2 Global POCT Molecular Diagnostics Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global POCT Molecular Diagnostics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global POCT Molecular Diagnostics Breakdown Data by Company
3.1.1 Global POCT Molecular Diagnostics Annual Sales by Company (2021-2026)
3.1.2 Global POCT Molecular Diagnostics Sales Market Share by Company (2021-2026)
3.2 Global POCT Molecular Diagnostics Annual Revenue by Company (2021-2026)
3.2.1 Global POCT Molecular Diagnostics Revenue by Company (2021-2026)
3.2.2 Global POCT Molecular Diagnostics Revenue Market Share by Company (2021-2026)
3.3 Global POCT Molecular Diagnostics Sale Price by Company
3.4 Key Manufacturers POCT Molecular Diagnostics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers POCT Molecular Diagnostics Product Location Distribution
3.4.2 Players POCT Molecular Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POCT MOLECULAR DIAGNOSTICS BY GEOGRAPHIC REGION
4.1 World Historic POCT Molecular Diagnostics Market Size by Geographic Region (2021-2026)
4.1.1 Global POCT Molecular Diagnostics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global POCT Molecular Diagnostics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic POCT Molecular Diagnostics Market Size by Country/Region (2021-2026)
4.2.1 Global POCT Molecular Diagnostics Annual Sales by Country/Region (2021-2026)
4.2.2 Global POCT Molecular Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas POCT Molecular Diagnostics Sales Growth
4.4 APAC POCT Molecular Diagnostics Sales Growth
4.5 Europe POCT Molecular Diagnostics Sales Growth
4.6 Middle East & Africa POCT Molecular Diagnostics Sales Growth
5 AMERICAS
5.1 Americas POCT Molecular Diagnostics Sales by Country
5.1.1 Americas POCT Molecular Diagnostics Sales by Country (2021-2026)
5.1.2 Americas POCT Molecular Diagnostics Revenue by Country (2021-2026)
5.2 Americas POCT Molecular Diagnostics Sales by Type (2021-2026)
5.3 Americas POCT Molecular Diagnostics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC POCT Molecular Diagnostics Sales by Region
6.1.1 APAC POCT Molecular Diagnostics Sales by Region (2021-2026)
6.1.2 APAC POCT Molecular Diagnostics Revenue by Region (2021-2026)
6.2 APAC POCT Molecular Diagnostics Sales by Type (2021-2026)
6.3 APAC POCT Molecular Diagnostics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe POCT Molecular Diagnostics by Country
7.1.1 Europe POCT Molecular Diagnostics Sales by Country (2021-2026)
7.1.2 Europe POCT Molecular Diagnostics Revenue by Country (2021-2026)
7.2 Europe POCT Molecular Diagnostics Sales by Type (2021-2026)
7.3 Europe POCT Molecular Diagnostics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa POCT Molecular Diagnostics by Country
8.1.1 Middle East & Africa POCT Molecular Diagnostics Sales by Country (2021-2026)
8.1.2 Middle East & Africa POCT Molecular Diagnostics Revenue by Country (2021-2026)
8.2 Middle East & Africa POCT Molecular Diagnostics Sales by Type (2021-2026)
8.3 Middle East & Africa POCT Molecular Diagnostics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of POCT Molecular Diagnostics
10.3 Manufacturing Process Analysis of POCT Molecular Diagnostics
10.4 Industry Chain Structure of POCT Molecular Diagnostics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 POCT Molecular Diagnostics Distributors
11.3 POCT Molecular Diagnostics Customer
12 WORLD FORECAST REVIEW FOR POCT MOLECULAR DIAGNOSTICS BY GEOGRAPHIC REGION
12.1 Global POCT Molecular Diagnostics Market Size Forecast by Region
12.1.1 Global POCT Molecular Diagnostics Forecast by Region (2027-2032)
12.1.2 Global POCT Molecular Diagnostics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global POCT Molecular Diagnostics Forecast by Type (2027-2032)
12.7 Global POCT Molecular Diagnostics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Ustar Biotechnologies (Hangzhou) Ltd.
13.1.1 Ustar Biotechnologies (Hangzhou) Ltd. Company Information
13.1.2 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
13.1.3 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Ustar Biotechnologies (Hangzhou) Ltd. Main Business Overview
13.1.5 Ustar Biotechnologies (Hangzhou) Ltd. Latest Developments
13.2 Cepheid
13.2.1 Cepheid Company Information
13.2.2 Cepheid POCT Molecular Diagnostics Product Portfolios and Specifications
13.2.3 Cepheid POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Cepheid Main Business Overview
13.2.5 Cepheid Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories POCT Molecular Diagnostics Product Portfolios and Specifications
13.3.3 Abbott Laboratories POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Roche Holding AG
13.4.1 Roche Holding AG Company Information
13.4.2 Roche Holding AG POCT Molecular Diagnostics Product Portfolios and Specifications
13.4.3 Roche Holding AG POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Roche Holding AG Main Business Overview
13.4.5 Roche Holding AG Latest Developments
13.5 BioFire Diagnostics
13.5.1 BioFire Diagnostics Company Information
13.5.2 BioFire Diagnostics POCT Molecular Diagnostics Product Portfolios and Specifications
13.5.3 BioFire Diagnostics POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BioFire Diagnostics Main Business Overview
13.5.5 BioFire Diagnostics Latest Developments
13.6 Beijing Bohui Innovat Biotech Grp Co Ltd.
13.6.1 Beijing Bohui Innovat Biotech Grp Co Ltd. Company Information
13.6.2 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
13.6.3 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Beijing Bohui Innovat Biotech Grp Co Ltd. Main Business Overview
13.6.5 Beijing Bohui Innovat Biotech Grp Co Ltd. Latest Developments
13.7 CapitalBio Corporation
13.7.1 CapitalBio Corporation Company Information
13.7.2 CapitalBio Corporation POCT Molecular Diagnostics Product Portfolios and Specifications
13.7.3 CapitalBio Corporation POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 CapitalBio Corporation Main Business Overview
13.7.5 CapitalBio Corporation Latest Developments
13.8 Daan Gene
13.8.1 Daan Gene Company Information
13.8.2 Daan Gene POCT Molecular Diagnostics Product Portfolios and Specifications
13.8.3 Daan Gene POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Daan Gene Main Business Overview
13.8.5 Daan Gene Latest Developments
13.9 Sansure Biotech
13.9.1 Sansure Biotech Company Information
13.9.2 Sansure Biotech POCT Molecular Diagnostics Product Portfolios and Specifications
13.9.3 Sansure Biotech POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sansure Biotech Main Business Overview
13.9.5 Sansure Biotech Latest Developments
13.10 Coyote Bioscience Co., Ltd.
13.10.1 Coyote Bioscience Co., Ltd. Company Information
13.10.2 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
13.10.3 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Coyote Bioscience Co., Ltd. Main Business Overview
13.10.5 Coyote Bioscience Co., Ltd. Latest Developments
13.11 Genmark Diagnostics, Inc.
13.11.1 Genmark Diagnostics, Inc. Company Information
13.11.2 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Product Portfolios and Specifications
13.11.3 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Genmark Diagnostics, Inc. Main Business Overview
13.11.5 Genmark Diagnostics, Inc. Latest Developments
13.12 Mobidiag
13.12.1 Mobidiag Company Information
13.12.2 Mobidiag POCT Molecular Diagnostics Product Portfolios and Specifications
13.12.3 Mobidiag POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Mobidiag Main Business Overview
13.12.5 Mobidiag Latest Developments
13.13 Wondfo
13.13.1 Wondfo Company Information
13.13.2 Wondfo POCT Molecular Diagnostics Product Portfolios and Specifications
13.13.3 Wondfo POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Wondfo Main Business Overview
13.13.5 Wondfo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global POCT Molecular Diagnostics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for POCT Molecular Diagnostics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for POCT Molecular Diagnostics by Country/Region, 2021, 2025 & 2032
2.2 POCT Molecular Diagnostics Segment by Type
2.2.1 Molecular Point-of-Care Diagnostics
2.2.2 Near-Patient Molecular
2.2.3 POCT Molecular Diagnostics Sales by Type
2.2.3.1 Global POCT Molecular Diagnostics Sales Market Share by Type (2021-2026)
2.2.3.2 Global POCT Molecular Diagnostics Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global POCT Molecular Diagnostics Sale Price by Type (2021-2026)
2.3 POCT Molecular Diagnostics Segment by Application
2.3.1 Microbiology Laboratory
2.3.2 Hospital
2.3.3 Clinic
2.3.4 POCT Molecular Diagnostics Sales by Application
2.3.4.1 Global POCT Molecular Diagnostics Sale Market Share by Application (2021-2026)
2.3.4.2 Global POCT Molecular Diagnostics Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global POCT Molecular Diagnostics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global POCT Molecular Diagnostics Breakdown Data by Company
3.1.1 Global POCT Molecular Diagnostics Annual Sales by Company (2021-2026)
3.1.2 Global POCT Molecular Diagnostics Sales Market Share by Company (2021-2026)
3.2 Global POCT Molecular Diagnostics Annual Revenue by Company (2021-2026)
3.2.1 Global POCT Molecular Diagnostics Revenue by Company (2021-2026)
3.2.2 Global POCT Molecular Diagnostics Revenue Market Share by Company (2021-2026)
3.3 Global POCT Molecular Diagnostics Sale Price by Company
3.4 Key Manufacturers POCT Molecular Diagnostics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers POCT Molecular Diagnostics Product Location Distribution
3.4.2 Players POCT Molecular Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POCT MOLECULAR DIAGNOSTICS BY GEOGRAPHIC REGION
4.1 World Historic POCT Molecular Diagnostics Market Size by Geographic Region (2021-2026)
4.1.1 Global POCT Molecular Diagnostics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global POCT Molecular Diagnostics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic POCT Molecular Diagnostics Market Size by Country/Region (2021-2026)
4.2.1 Global POCT Molecular Diagnostics Annual Sales by Country/Region (2021-2026)
4.2.2 Global POCT Molecular Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas POCT Molecular Diagnostics Sales Growth
4.4 APAC POCT Molecular Diagnostics Sales Growth
4.5 Europe POCT Molecular Diagnostics Sales Growth
4.6 Middle East & Africa POCT Molecular Diagnostics Sales Growth
5 AMERICAS
5.1 Americas POCT Molecular Diagnostics Sales by Country
5.1.1 Americas POCT Molecular Diagnostics Sales by Country (2021-2026)
5.1.2 Americas POCT Molecular Diagnostics Revenue by Country (2021-2026)
5.2 Americas POCT Molecular Diagnostics Sales by Type (2021-2026)
5.3 Americas POCT Molecular Diagnostics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC POCT Molecular Diagnostics Sales by Region
6.1.1 APAC POCT Molecular Diagnostics Sales by Region (2021-2026)
6.1.2 APAC POCT Molecular Diagnostics Revenue by Region (2021-2026)
6.2 APAC POCT Molecular Diagnostics Sales by Type (2021-2026)
6.3 APAC POCT Molecular Diagnostics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe POCT Molecular Diagnostics by Country
7.1.1 Europe POCT Molecular Diagnostics Sales by Country (2021-2026)
7.1.2 Europe POCT Molecular Diagnostics Revenue by Country (2021-2026)
7.2 Europe POCT Molecular Diagnostics Sales by Type (2021-2026)
7.3 Europe POCT Molecular Diagnostics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa POCT Molecular Diagnostics by Country
8.1.1 Middle East & Africa POCT Molecular Diagnostics Sales by Country (2021-2026)
8.1.2 Middle East & Africa POCT Molecular Diagnostics Revenue by Country (2021-2026)
8.2 Middle East & Africa POCT Molecular Diagnostics Sales by Type (2021-2026)
8.3 Middle East & Africa POCT Molecular Diagnostics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of POCT Molecular Diagnostics
10.3 Manufacturing Process Analysis of POCT Molecular Diagnostics
10.4 Industry Chain Structure of POCT Molecular Diagnostics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 POCT Molecular Diagnostics Distributors
11.3 POCT Molecular Diagnostics Customer
12 WORLD FORECAST REVIEW FOR POCT MOLECULAR DIAGNOSTICS BY GEOGRAPHIC REGION
12.1 Global POCT Molecular Diagnostics Market Size Forecast by Region
12.1.1 Global POCT Molecular Diagnostics Forecast by Region (2027-2032)
12.1.2 Global POCT Molecular Diagnostics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global POCT Molecular Diagnostics Forecast by Type (2027-2032)
12.7 Global POCT Molecular Diagnostics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Ustar Biotechnologies (Hangzhou) Ltd.
13.1.1 Ustar Biotechnologies (Hangzhou) Ltd. Company Information
13.1.2 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
13.1.3 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Ustar Biotechnologies (Hangzhou) Ltd. Main Business Overview
13.1.5 Ustar Biotechnologies (Hangzhou) Ltd. Latest Developments
13.2 Cepheid
13.2.1 Cepheid Company Information
13.2.2 Cepheid POCT Molecular Diagnostics Product Portfolios and Specifications
13.2.3 Cepheid POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Cepheid Main Business Overview
13.2.5 Cepheid Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories POCT Molecular Diagnostics Product Portfolios and Specifications
13.3.3 Abbott Laboratories POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Roche Holding AG
13.4.1 Roche Holding AG Company Information
13.4.2 Roche Holding AG POCT Molecular Diagnostics Product Portfolios and Specifications
13.4.3 Roche Holding AG POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Roche Holding AG Main Business Overview
13.4.5 Roche Holding AG Latest Developments
13.5 BioFire Diagnostics
13.5.1 BioFire Diagnostics Company Information
13.5.2 BioFire Diagnostics POCT Molecular Diagnostics Product Portfolios and Specifications
13.5.3 BioFire Diagnostics POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BioFire Diagnostics Main Business Overview
13.5.5 BioFire Diagnostics Latest Developments
13.6 Beijing Bohui Innovat Biotech Grp Co Ltd.
13.6.1 Beijing Bohui Innovat Biotech Grp Co Ltd. Company Information
13.6.2 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
13.6.3 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Beijing Bohui Innovat Biotech Grp Co Ltd. Main Business Overview
13.6.5 Beijing Bohui Innovat Biotech Grp Co Ltd. Latest Developments
13.7 CapitalBio Corporation
13.7.1 CapitalBio Corporation Company Information
13.7.2 CapitalBio Corporation POCT Molecular Diagnostics Product Portfolios and Specifications
13.7.3 CapitalBio Corporation POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 CapitalBio Corporation Main Business Overview
13.7.5 CapitalBio Corporation Latest Developments
13.8 Daan Gene
13.8.1 Daan Gene Company Information
13.8.2 Daan Gene POCT Molecular Diagnostics Product Portfolios and Specifications
13.8.3 Daan Gene POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Daan Gene Main Business Overview
13.8.5 Daan Gene Latest Developments
13.9 Sansure Biotech
13.9.1 Sansure Biotech Company Information
13.9.2 Sansure Biotech POCT Molecular Diagnostics Product Portfolios and Specifications
13.9.3 Sansure Biotech POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sansure Biotech Main Business Overview
13.9.5 Sansure Biotech Latest Developments
13.10 Coyote Bioscience Co., Ltd.
13.10.1 Coyote Bioscience Co., Ltd. Company Information
13.10.2 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
13.10.3 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Coyote Bioscience Co., Ltd. Main Business Overview
13.10.5 Coyote Bioscience Co., Ltd. Latest Developments
13.11 Genmark Diagnostics, Inc.
13.11.1 Genmark Diagnostics, Inc. Company Information
13.11.2 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Product Portfolios and Specifications
13.11.3 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Genmark Diagnostics, Inc. Main Business Overview
13.11.5 Genmark Diagnostics, Inc. Latest Developments
13.12 Mobidiag
13.12.1 Mobidiag Company Information
13.12.2 Mobidiag POCT Molecular Diagnostics Product Portfolios and Specifications
13.12.3 Mobidiag POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Mobidiag Main Business Overview
13.12.5 Mobidiag Latest Developments
13.13 Wondfo
13.13.1 Wondfo Company Information
13.13.2 Wondfo POCT Molecular Diagnostics Product Portfolios and Specifications
13.13.3 Wondfo POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Wondfo Main Business Overview
13.13.5 Wondfo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. POCT Molecular Diagnostics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. POCT Molecular Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Molecular Point-of-Care Diagnostics
Table 4. Major Players of Near-Patient Molecular
Table 5. Global POCT Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 6. Global POCT Molecular Diagnostics Sales Market Share by Type (2021-2026)
Table 7. Global POCT Molecular Diagnostics Revenue by Type (2021-2026) & ($ million)
Table 8. Global POCT Molecular Diagnostics Revenue Market Share by Type (2021-2026)
Table 9. Global POCT Molecular Diagnostics Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global POCT Molecular Diagnostics Sale by Application (2021-2026) & (K Units)
Table 11. Global POCT Molecular Diagnostics Sale Market Share by Application (2021-2026)
Table 12. Global POCT Molecular Diagnostics Revenue by Application (2021-2026) & ($ million)
Table 13. Global POCT Molecular Diagnostics Revenue Market Share by Application (2021-2026)
Table 14. Global POCT Molecular Diagnostics Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global POCT Molecular Diagnostics Sales by Company (2021-2026) & (K Units)
Table 16. Global POCT Molecular Diagnostics Sales Market Share by Company (2021-2026)
Table 17. Global POCT Molecular Diagnostics Revenue by Company (2021-2026) & ($ millions)
Table 18. Global POCT Molecular Diagnostics Revenue Market Share by Company (2021-2026)
Table 19. Global POCT Molecular Diagnostics Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers POCT Molecular Diagnostics Producing Area Distribution and Sales Area
Table 21. Players POCT Molecular Diagnostics Products Offered
Table 22. POCT Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global POCT Molecular Diagnostics Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global POCT Molecular Diagnostics Sales Market Share Geographic Region (2021-2026)
Table 27. Global POCT Molecular Diagnostics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global POCT Molecular Diagnostics Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global POCT Molecular Diagnostics Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global POCT Molecular Diagnostics Sales Market Share by Country/Region (2021-2026)
Table 31. Global POCT Molecular Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global POCT Molecular Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas POCT Molecular Diagnostics Sales by Country (2021-2026) & (K Units)
Table 34. Americas POCT Molecular Diagnostics Sales Market Share by Country (2021-2026)
Table 35. Americas POCT Molecular Diagnostics Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas POCT Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 37. Americas POCT Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 38. APAC POCT Molecular Diagnostics Sales by Region (2021-2026) & (K Units)
Table 39. APAC POCT Molecular Diagnostics Sales Market Share by Region (2021-2026)
Table 40. APAC POCT Molecular Diagnostics Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC POCT Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 42. APAC POCT Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 43. Europe POCT Molecular Diagnostics Sales by Country (2021-2026) & (K Units)
Table 44. Europe POCT Molecular Diagnostics Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe POCT Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 46. Europe POCT Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa POCT Molecular Diagnostics Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa POCT Molecular Diagnostics Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa POCT Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa POCT Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of POCT Molecular Diagnostics
Table 52. Key Market Challenges & Risks of POCT Molecular Diagnostics
Table 53. Key Industry Trends of POCT Molecular Diagnostics
Table 54. POCT Molecular Diagnostics Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. POCT Molecular Diagnostics Distributors List
Table 57. POCT Molecular Diagnostics Customer List
Table 58. Global POCT Molecular Diagnostics Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global POCT Molecular Diagnostics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas POCT Molecular Diagnostics Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas POCT Molecular Diagnostics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC POCT Molecular Diagnostics Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC POCT Molecular Diagnostics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe POCT Molecular Diagnostics Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe POCT Molecular Diagnostics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa POCT Molecular Diagnostics Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa POCT Molecular Diagnostics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global POCT Molecular Diagnostics Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global POCT Molecular Diagnostics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global POCT Molecular Diagnostics Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global POCT Molecular Diagnostics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Ustar Biotechnologies (Hangzhou) Ltd. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 73. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 74. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Ustar Biotechnologies (Hangzhou) Ltd. Main Business
Table 76. Ustar Biotechnologies (Hangzhou) Ltd. Latest Developments
Table 77. Cepheid Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 78. Cepheid POCT Molecular Diagnostics Product Portfolios and Specifications
Table 79. Cepheid POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Cepheid Main Business
Table 81. Cepheid Latest Developments
Table 82. Abbott Laboratories Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 83. Abbott Laboratories POCT Molecular Diagnostics Product Portfolios and Specifications
Table 84. Abbott Laboratories POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Abbott Laboratories Main Business
Table 86. Abbott Laboratories Latest Developments
Table 87. Roche Holding AG Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche Holding AG POCT Molecular Diagnostics Product Portfolios and Specifications
Table 89. Roche Holding AG POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Roche Holding AG Main Business
Table 91. Roche Holding AG Latest Developments
Table 92. BioFire Diagnostics Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 93. BioFire Diagnostics POCT Molecular Diagnostics Product Portfolios and Specifications
Table 94. BioFire Diagnostics POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. BioFire Diagnostics Main Business
Table 96. BioFire Diagnostics Latest Developments
Table 97. Beijing Bohui Innovat Biotech Grp Co Ltd. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 98. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 99. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Beijing Bohui Innovat Biotech Grp Co Ltd. Main Business
Table 101. Beijing Bohui Innovat Biotech Grp Co Ltd. Latest Developments
Table 102. CapitalBio Corporation Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 103. CapitalBio Corporation POCT Molecular Diagnostics Product Portfolios and Specifications
Table 104. CapitalBio Corporation POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. CapitalBio Corporation Main Business
Table 106. CapitalBio Corporation Latest Developments
Table 107. Daan Gene Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 108. Daan Gene POCT Molecular Diagnostics Product Portfolios and Specifications
Table 109. Daan Gene POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Daan Gene Main Business
Table 111. Daan Gene Latest Developments
Table 112. Sansure Biotech Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 113. Sansure Biotech POCT Molecular Diagnostics Product Portfolios and Specifications
Table 114. Sansure Biotech POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Sansure Biotech Main Business
Table 116. Sansure Biotech Latest Developments
Table 117. Coyote Bioscience Co., Ltd. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 118. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 119. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Coyote Bioscience Co., Ltd. Main Business
Table 121. Coyote Bioscience Co., Ltd. Latest Developments
Table 122. Genmark Diagnostics, Inc. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 123. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 124. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Genmark Diagnostics, Inc. Main Business
Table 126. Genmark Diagnostics, Inc. Latest Developments
Table 127. Mobidiag Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 128. Mobidiag POCT Molecular Diagnostics Product Portfolios and Specifications
Table 129. Mobidiag POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Mobidiag Main Business
Table 131. Mobidiag Latest Developments
Table 132. Wondfo Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 133. Wondfo POCT Molecular Diagnostics Product Portfolios and Specifications
Table 134. Wondfo POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Wondfo Main Business
Table 136. Wondfo Latest Developments
Table 1. POCT Molecular Diagnostics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. POCT Molecular Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Molecular Point-of-Care Diagnostics
Table 4. Major Players of Near-Patient Molecular
Table 5. Global POCT Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 6. Global POCT Molecular Diagnostics Sales Market Share by Type (2021-2026)
Table 7. Global POCT Molecular Diagnostics Revenue by Type (2021-2026) & ($ million)
Table 8. Global POCT Molecular Diagnostics Revenue Market Share by Type (2021-2026)
Table 9. Global POCT Molecular Diagnostics Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global POCT Molecular Diagnostics Sale by Application (2021-2026) & (K Units)
Table 11. Global POCT Molecular Diagnostics Sale Market Share by Application (2021-2026)
Table 12. Global POCT Molecular Diagnostics Revenue by Application (2021-2026) & ($ million)
Table 13. Global POCT Molecular Diagnostics Revenue Market Share by Application (2021-2026)
Table 14. Global POCT Molecular Diagnostics Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global POCT Molecular Diagnostics Sales by Company (2021-2026) & (K Units)
Table 16. Global POCT Molecular Diagnostics Sales Market Share by Company (2021-2026)
Table 17. Global POCT Molecular Diagnostics Revenue by Company (2021-2026) & ($ millions)
Table 18. Global POCT Molecular Diagnostics Revenue Market Share by Company (2021-2026)
Table 19. Global POCT Molecular Diagnostics Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers POCT Molecular Diagnostics Producing Area Distribution and Sales Area
Table 21. Players POCT Molecular Diagnostics Products Offered
Table 22. POCT Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global POCT Molecular Diagnostics Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global POCT Molecular Diagnostics Sales Market Share Geographic Region (2021-2026)
Table 27. Global POCT Molecular Diagnostics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global POCT Molecular Diagnostics Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global POCT Molecular Diagnostics Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global POCT Molecular Diagnostics Sales Market Share by Country/Region (2021-2026)
Table 31. Global POCT Molecular Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global POCT Molecular Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas POCT Molecular Diagnostics Sales by Country (2021-2026) & (K Units)
Table 34. Americas POCT Molecular Diagnostics Sales Market Share by Country (2021-2026)
Table 35. Americas POCT Molecular Diagnostics Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas POCT Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 37. Americas POCT Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 38. APAC POCT Molecular Diagnostics Sales by Region (2021-2026) & (K Units)
Table 39. APAC POCT Molecular Diagnostics Sales Market Share by Region (2021-2026)
Table 40. APAC POCT Molecular Diagnostics Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC POCT Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 42. APAC POCT Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 43. Europe POCT Molecular Diagnostics Sales by Country (2021-2026) & (K Units)
Table 44. Europe POCT Molecular Diagnostics Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe POCT Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 46. Europe POCT Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa POCT Molecular Diagnostics Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa POCT Molecular Diagnostics Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa POCT Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa POCT Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of POCT Molecular Diagnostics
Table 52. Key Market Challenges & Risks of POCT Molecular Diagnostics
Table 53. Key Industry Trends of POCT Molecular Diagnostics
Table 54. POCT Molecular Diagnostics Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. POCT Molecular Diagnostics Distributors List
Table 57. POCT Molecular Diagnostics Customer List
Table 58. Global POCT Molecular Diagnostics Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global POCT Molecular Diagnostics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas POCT Molecular Diagnostics Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas POCT Molecular Diagnostics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC POCT Molecular Diagnostics Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC POCT Molecular Diagnostics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe POCT Molecular Diagnostics Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe POCT Molecular Diagnostics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa POCT Molecular Diagnostics Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa POCT Molecular Diagnostics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global POCT Molecular Diagnostics Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global POCT Molecular Diagnostics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global POCT Molecular Diagnostics Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global POCT Molecular Diagnostics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Ustar Biotechnologies (Hangzhou) Ltd. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 73. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 74. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Ustar Biotechnologies (Hangzhou) Ltd. Main Business
Table 76. Ustar Biotechnologies (Hangzhou) Ltd. Latest Developments
Table 77. Cepheid Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 78. Cepheid POCT Molecular Diagnostics Product Portfolios and Specifications
Table 79. Cepheid POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Cepheid Main Business
Table 81. Cepheid Latest Developments
Table 82. Abbott Laboratories Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 83. Abbott Laboratories POCT Molecular Diagnostics Product Portfolios and Specifications
Table 84. Abbott Laboratories POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Abbott Laboratories Main Business
Table 86. Abbott Laboratories Latest Developments
Table 87. Roche Holding AG Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche Holding AG POCT Molecular Diagnostics Product Portfolios and Specifications
Table 89. Roche Holding AG POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Roche Holding AG Main Business
Table 91. Roche Holding AG Latest Developments
Table 92. BioFire Diagnostics Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 93. BioFire Diagnostics POCT Molecular Diagnostics Product Portfolios and Specifications
Table 94. BioFire Diagnostics POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. BioFire Diagnostics Main Business
Table 96. BioFire Diagnostics Latest Developments
Table 97. Beijing Bohui Innovat Biotech Grp Co Ltd. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 98. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 99. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Beijing Bohui Innovat Biotech Grp Co Ltd. Main Business
Table 101. Beijing Bohui Innovat Biotech Grp Co Ltd. Latest Developments
Table 102. CapitalBio Corporation Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 103. CapitalBio Corporation POCT Molecular Diagnostics Product Portfolios and Specifications
Table 104. CapitalBio Corporation POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. CapitalBio Corporation Main Business
Table 106. CapitalBio Corporation Latest Developments
Table 107. Daan Gene Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 108. Daan Gene POCT Molecular Diagnostics Product Portfolios and Specifications
Table 109. Daan Gene POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Daan Gene Main Business
Table 111. Daan Gene Latest Developments
Table 112. Sansure Biotech Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 113. Sansure Biotech POCT Molecular Diagnostics Product Portfolios and Specifications
Table 114. Sansure Biotech POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Sansure Biotech Main Business
Table 116. Sansure Biotech Latest Developments
Table 117. Coyote Bioscience Co., Ltd. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 118. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 119. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Coyote Bioscience Co., Ltd. Main Business
Table 121. Coyote Bioscience Co., Ltd. Latest Developments
Table 122. Genmark Diagnostics, Inc. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 123. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 124. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Genmark Diagnostics, Inc. Main Business
Table 126. Genmark Diagnostics, Inc. Latest Developments
Table 127. Mobidiag Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 128. Mobidiag POCT Molecular Diagnostics Product Portfolios and Specifications
Table 129. Mobidiag POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Mobidiag Main Business
Table 131. Mobidiag Latest Developments
Table 132. Wondfo Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 133. Wondfo POCT Molecular Diagnostics Product Portfolios and Specifications
Table 134. Wondfo POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Wondfo Main Business
Table 136. Wondfo Latest Developments
LIST OF FIGURES
Figure 1. Picture of POCT Molecular Diagnostics
Figure 2. POCT Molecular Diagnostics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global POCT Molecular Diagnostics Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global POCT Molecular Diagnostics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. POCT Molecular Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. POCT Molecular Diagnostics Sales Market Share by Country/Region (2025)
Figure 10. POCT Molecular Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Molecular Point-of-Care Diagnostics
Figure 12. Product Picture of Near-Patient Molecular
Figure 13. Global POCT Molecular Diagnostics Sales Market Share by Type in 2026
Figure 14. Global POCT Molecular Diagnostics Revenue Market Share by Type (2021-2026)
Figure 15. POCT Molecular Diagnostics Consumed in Microbiology Laboratory
Figure 16. Global POCT Molecular Diagnostics Market: Microbiology Laboratory (2021-2026) & (K Units)
Figure 17. POCT Molecular Diagnostics Consumed in Hospital
Figure 18. Global POCT Molecular Diagnostics Market: Hospital (2021-2026) & (K Units)
Figure 19. POCT Molecular Diagnostics Consumed in Clinic
Figure 20. Global POCT Molecular Diagnostics Market: Clinic (2021-2026) & (K Units)
Figure 21. Global POCT Molecular Diagnostics Sale Market Share by Application (2025)
Figure 22. Global POCT Molecular Diagnostics Revenue Market Share by Application in 2026
Figure 23. POCT Molecular Diagnostics Sales by Company in 2026 (K Units)
Figure 24. Global POCT Molecular Diagnostics Sales Market Share by Company in 2026
Figure 25. POCT Molecular Diagnostics Revenue by Company in 2026 ($ millions)
Figure 26. Global POCT Molecular Diagnostics Revenue Market Share by Company in 2026
Figure 27. Global POCT Molecular Diagnostics Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global POCT Molecular Diagnostics Revenue Market Share by Geographic Region in 2026
Figure 29. Americas POCT Molecular Diagnostics Sales 2021-2026 (K Units)
Figure 30. Americas POCT Molecular Diagnostics Revenue 2021-2026 ($ millions)
Figure 31. APAC POCT Molecular Diagnostics Sales 2021-2026 (K Units)
Figure 32. APAC POCT Molecular Diagnostics Revenue 2021-2026 ($ millions)
Figure 33. Europe POCT Molecular Diagnostics Sales 2021-2026 (K Units)
Figure 34. Europe POCT Molecular Diagnostics Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa POCT Molecular Diagnostics Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa POCT Molecular Diagnostics Revenue 2021-2026 ($ millions)
Figure 37. Americas POCT Molecular Diagnostics Sales Market Share by Country in 2026
Figure 38. Americas POCT Molecular Diagnostics Revenue Market Share by Country (2021-2026)
Figure 39. Americas POCT Molecular Diagnostics Sales Market Share by Type (2021-2026)
Figure 40. Americas POCT Molecular Diagnostics Sales Market Share by Application (2021-2026)
Figure 41. United States POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC POCT Molecular Diagnostics Sales Market Share by Region in 2026
Figure 46. APAC POCT Molecular Diagnostics Revenue Market Share by Region (2021-2026)
Figure 47. APAC POCT Molecular Diagnostics Sales Market Share by Type (2021-2026)
Figure 48. APAC POCT Molecular Diagnostics Sales Market Share by Application (2021-2026)
Figure 49. China POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 53. India POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe POCT Molecular Diagnostics Sales Market Share by Country in 2026
Figure 57. Europe POCT Molecular Diagnostics Revenue Market Share by Country (2021-2026)
Figure 58. Europe POCT Molecular Diagnostics Sales Market Share by Type (2021-2026)
Figure 59. Europe POCT Molecular Diagnostics Sales Market Share by Application (2021-2026)
Figure 60. Germany POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 61. France POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 62. UK POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Application (2021-2026)
Figure 68. Egypt POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of POCT Molecular Diagnostics in 2026
Figure 74. Manufacturing Process Analysis of POCT Molecular Diagnostics
Figure 75. Industry Chain Structure of POCT Molecular Diagnostics
Figure 76. Channels of Distribution
Figure 77. Global POCT Molecular Diagnostics Sales Market Forecast by Region (2027-2032)
Figure 78. Global POCT Molecular Diagnostics Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global POCT Molecular Diagnostics Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global POCT Molecular Diagnostics Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global POCT Molecular Diagnostics Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global POCT Molecular Diagnostics Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of POCT Molecular Diagnostics
Figure 2. POCT Molecular Diagnostics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global POCT Molecular Diagnostics Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global POCT Molecular Diagnostics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. POCT Molecular Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. POCT Molecular Diagnostics Sales Market Share by Country/Region (2025)
Figure 10. POCT Molecular Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Molecular Point-of-Care Diagnostics
Figure 12. Product Picture of Near-Patient Molecular
Figure 13. Global POCT Molecular Diagnostics Sales Market Share by Type in 2026
Figure 14. Global POCT Molecular Diagnostics Revenue Market Share by Type (2021-2026)
Figure 15. POCT Molecular Diagnostics Consumed in Microbiology Laboratory
Figure 16. Global POCT Molecular Diagnostics Market: Microbiology Laboratory (2021-2026) & (K Units)
Figure 17. POCT Molecular Diagnostics Consumed in Hospital
Figure 18. Global POCT Molecular Diagnostics Market: Hospital (2021-2026) & (K Units)
Figure 19. POCT Molecular Diagnostics Consumed in Clinic
Figure 20. Global POCT Molecular Diagnostics Market: Clinic (2021-2026) & (K Units)
Figure 21. Global POCT Molecular Diagnostics Sale Market Share by Application (2025)
Figure 22. Global POCT Molecular Diagnostics Revenue Market Share by Application in 2026
Figure 23. POCT Molecular Diagnostics Sales by Company in 2026 (K Units)
Figure 24. Global POCT Molecular Diagnostics Sales Market Share by Company in 2026
Figure 25. POCT Molecular Diagnostics Revenue by Company in 2026 ($ millions)
Figure 26. Global POCT Molecular Diagnostics Revenue Market Share by Company in 2026
Figure 27. Global POCT Molecular Diagnostics Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global POCT Molecular Diagnostics Revenue Market Share by Geographic Region in 2026
Figure 29. Americas POCT Molecular Diagnostics Sales 2021-2026 (K Units)
Figure 30. Americas POCT Molecular Diagnostics Revenue 2021-2026 ($ millions)
Figure 31. APAC POCT Molecular Diagnostics Sales 2021-2026 (K Units)
Figure 32. APAC POCT Molecular Diagnostics Revenue 2021-2026 ($ millions)
Figure 33. Europe POCT Molecular Diagnostics Sales 2021-2026 (K Units)
Figure 34. Europe POCT Molecular Diagnostics Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa POCT Molecular Diagnostics Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa POCT Molecular Diagnostics Revenue 2021-2026 ($ millions)
Figure 37. Americas POCT Molecular Diagnostics Sales Market Share by Country in 2026
Figure 38. Americas POCT Molecular Diagnostics Revenue Market Share by Country (2021-2026)
Figure 39. Americas POCT Molecular Diagnostics Sales Market Share by Type (2021-2026)
Figure 40. Americas POCT Molecular Diagnostics Sales Market Share by Application (2021-2026)
Figure 41. United States POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC POCT Molecular Diagnostics Sales Market Share by Region in 2026
Figure 46. APAC POCT Molecular Diagnostics Revenue Market Share by Region (2021-2026)
Figure 47. APAC POCT Molecular Diagnostics Sales Market Share by Type (2021-2026)
Figure 48. APAC POCT Molecular Diagnostics Sales Market Share by Application (2021-2026)
Figure 49. China POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 53. India POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe POCT Molecular Diagnostics Sales Market Share by Country in 2026
Figure 57. Europe POCT Molecular Diagnostics Revenue Market Share by Country (2021-2026)
Figure 58. Europe POCT Molecular Diagnostics Sales Market Share by Type (2021-2026)
Figure 59. Europe POCT Molecular Diagnostics Sales Market Share by Application (2021-2026)
Figure 60. Germany POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 61. France POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 62. UK POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Application (2021-2026)
Figure 68. Egypt POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries POCT Molecular Diagnostics Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of POCT Molecular Diagnostics in 2026
Figure 74. Manufacturing Process Analysis of POCT Molecular Diagnostics
Figure 75. Industry Chain Structure of POCT Molecular Diagnostics
Figure 76. Channels of Distribution
Figure 77. Global POCT Molecular Diagnostics Sales Market Forecast by Region (2027-2032)
Figure 78. Global POCT Molecular Diagnostics Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global POCT Molecular Diagnostics Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global POCT Molecular Diagnostics Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global POCT Molecular Diagnostics Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global POCT Molecular Diagnostics Revenue Market Share Forecast by Application (2027-2032)
More Publications
Global Crank Arm Fixing Bolt Market Growth 2024-2030
US$ 3,660.00
June 2024
133 pages
Global Dandy-Walker Syndrome Treatment Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
June 2024
88 pages
Global Pazopanib Market Growth 2025-2031
US$ 3,660.00
December 2025
84 pages
Global Bariatric Products Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
112 pages
